Trade Windtree Therapeutics, Inc. - WINT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0286 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.2187 |
| Open | 0.2181 |
| 1-Year Change | -61.5% |
| Day's Range | 0.2046 - 0.2197 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 17, 2025 | 0.2046 | -0.0119 | -5.50% | 0.2165 | 0.2206 | 0.2046 |
| Jan 16, 2025 | 0.2187 | -0.0024 | -1.09% | 0.2211 | 0.2316 | 0.2024 |
| Jan 15, 2025 | 0.2365 | -0.0041 | -1.70% | 0.2406 | 0.2651 | 0.1971 |
| Jan 14, 2025 | 0.2421 | -0.0005 | -0.21% | 0.2426 | 0.2520 | 0.2317 |
| Jan 13, 2025 | 0.2359 | -0.0097 | -3.95% | 0.2456 | 0.2505 | 0.2269 |
| Jan 10, 2025 | 0.2505 | -0.0149 | -5.61% | 0.2654 | 0.2665 | 0.2448 |
| Jan 8, 2025 | 0.2643 | -0.0261 | -8.99% | 0.2904 | 0.2904 | 0.2465 |
| Jan 7, 2025 | 0.2790 | -0.0213 | -7.09% | 0.3003 | 0.3183 | 0.2790 |
| Jan 6, 2025 | 0.2958 | -0.0106 | -3.46% | 0.3064 | 0.3163 | 0.2839 |
| Jan 3, 2025 | 0.3092 | -0.0260 | -7.76% | 0.3352 | 0.3451 | 0.2988 |
| Jan 2, 2025 | 0.3332 | -0.0070 | -2.06% | 0.3402 | 0.3865 | 0.3150 |
| Dec 31, 2024 | 0.3183 | 0.0036 | 1.14% | 0.3147 | 0.3430 | 0.3010 |
| Dec 30, 2024 | 0.3003 | 0.0047 | 1.59% | 0.2956 | 0.3068 | 0.2834 |
| Dec 27, 2024 | 0.2945 | -0.0108 | -3.54% | 0.3053 | 0.3402 | 0.2910 |
| Dec 26, 2024 | 0.3023 | -0.0031 | -1.02% | 0.3054 | 0.3206 | 0.2868 |
| Dec 24, 2024 | 0.2989 | -0.0165 | -5.23% | 0.3154 | 0.3188 | 0.2820 |
| Dec 23, 2024 | 0.3154 | -0.0048 | -1.50% | 0.3202 | 0.3268 | 0.3007 |
| Dec 20, 2024 | 0.3262 | 0.0050 | 1.56% | 0.3212 | 0.3341 | 0.3029 |
| Dec 19, 2024 | 0.3053 | -0.0458 | -13.04% | 0.3511 | 0.3511 | 0.3053 |
| Dec 18, 2024 | 0.3440 | -0.0191 | -5.26% | 0.3631 | 0.3750 | 0.3440 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Windtree Therapeutics Inc. Company profile
About Windtree Therapeutics Inc
Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company. The Company’s development programs are primarily focused on the treatment of acute cardiovascular and acute pulmonary diseases. The Company’s cardiovascular programs includes Istaroxime (Early Cardiogenic Shock), Istaroxime (acute heart failure), Rostafuroxin and Oral SERCA2a Activators. Its Pulmonary Programs include Lyophilized KL4 Surfactant and AEROSURF (aerosolized KL4 surfactant based on Aerosol Delivery System technology). The Company’s subsidiaries Discovery Laboratories, Inc., CVie Investments Limited and CVie Therapeutics Limited.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Windtree Therapeutics Inc revenues was not reported. Net loss increased from $25.1M to $54.6M. Higher net loss reflects Research and development - Balancing val increase of 8% to $11.1M (expense), Stock-based Compensation in R and D increase of 39% to $2.3M (expense), Stock-based Compensation in SGA increase of 21% to $3.4M (expense).
Equity composition
Common Stock $.015 Par, 04/11, 50M auth., 13,822,000 issd., less 21,000 shs. in Treas. @ $3.1M. Insiders own 1.88%. *NOTE: 12/97 Name changed from Ansan Pharmaceuticals; FY'00 Qs are restated. *2/05, PO 5.06M shares @ $5.75 by SG Cowen & Co., LLC. 12/10, 1-for-15 reverse split. 01/06, 1-for-14 reverse stock split
| Industry: | Biotechnology & Medical Research (NEC) |
2600 Kelly Rd Ste 100
WARRINGTON
PENNSYLVANIA 18976-3652
US
News
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com